Using e-cigs, cigs, heated tobacco products, or marijuana once a day increases risk of heart arrythmias and causes remodeling of the heart

Huiliang Qiu, Matt Springer, and colleagues’ paper “Increased vulnerability to atrial and ventricular arrhythmias caused by different types of inhaled tobacco or marijuana products” makes two important points: (1) even very short daily exposures to tobacco and marijuana products have serious cumulative effects on the heart, and (2) nicotine and THC, the psychoactive components ofContinue reading Using e-cigs, cigs, heated tobacco products, or marijuana once a day increases risk of heart arrythmias and causes remodeling of the heart

Members of the scientific network used to promote “tobacco harm reduction” often don’t disclose industry ties

The tobacco industry has a long history of supporting scientists, often quietly, to establish narratives that promote its interests.  Now Julia Vassey, Yogi Hendlin, Manali Vora, and Pam Ling have published a formal analysis showing the network of scientists publishing papers on “tobacco harm reduction,” the core ideology used to justify promoting e-cigarettes and manyContinue reading “Members of the scientific network used to promote “tobacco harm reduction” often don’t disclose industry ties”

Regan-Udall Foundation review of FDA tobacco regulation “listening sessions” dominated by pro-industry speakers

Regan-Udall Foundation review of FDA tobacco regulation “listening sessions” dominated by pro-industry speakers The FDA has asked the Regan-Udall Foundation for recommendations on how to improve tobacco product regulation.  The Foundation’s Tobacco Independent Expert Panel has had three “listening sessions” that have been dominated by industry players and “harm reduction” advocates.  I have previously expressedContinue reading Regan-Udall Foundation review of FDA tobacco regulation “listening sessions” dominated by pro-industry speakers

FDA should not grant exemptions to its proposed standard banning menthol in cigarettes that would continue to allow menthol heated tobacco products or low nicotine cigarettes

FDA’s proposed standard banning menthol in cigarettes is very well-done except for its provision that would allow FDA to exempt heated tobacco products like Philip Morris’ IQOS, BAT’s glo or JTI’s Ploom — which are considered “cigarettes” under the law — or low nicotine cigarettes. (FDA has only authorized sale IQOS so far.) This isContinue reading “FDA should not grant exemptions to its proposed standard banning menthol in cigarettes that would continue to allow menthol heated tobacco products or low nicotine cigarettes”

FDA science leader Matt Holman leaves FDA for PMI

Matt Holman, who has served as head of the FDA Center for Tobacco Products since 2017, is leaving the FDA to take a job with Philip Morris International. According to a story in The Hill, a spokesperson for Philip Morris said Holman “is committed to helping existing adult smokers access scientifically substantiated smoke-free alternatives whileContinue reading “FDA science leader Matt Holman leaves FDA for PMI”

Support for cigarette menthol ban and cigar flavor ban; need to ban menthol as an ingredient not just as a characterizing flavor and to eliminate exceptions for some tobacco products (Statement at June 13, 2022 FDA Listening Session)

My name is Stanton Glantz.  I am a retired Professor of Medicine at the University of California San Francisco and was the principal investigator of the UCSF Tobacco Center of Regulatory Science. The FDA did an excellent job of summarizing the science on the effects of menthol to build a justification for ending the useContinue reading “Support for cigarette menthol ban and cigar flavor ban; need to ban menthol as an ingredient not just as a characterizing flavor and to eliminate exceptions for some tobacco products (Statement at June 13, 2022 FDA Listening Session)”

FDA does JT/Logic’s work for it to justify authorizing 3 of its ENDS

On March 24, 2022 FDA authorized the sale of three electronic nicotine delivery systems distributed by Japan Tobacco’s US company Logic Technology Development, – two conventional e-cigarettes and one heated tobacco product.  FDA withheld the Technical Project Lead (TPL) report that provides the scientific justifications for its decision. Thanks to my colleague Lauren Lempert filingContinue reading “FDA does JT/Logic’s work for it to justify authorizing 3 of its ENDS”

FDA proposed updating its HPHC list in 2019; it needs to finish the job

One of the nerdy, but very important, parts of the FDA tobacco product regulatory process is the list of “Hazardous and Potentially Hazardous Compounds” (HPHC) list that FDA released in 2012. This list contains 93 bad chemicals — mostly carcinogens — that FDA identified as important when assessing the risks of tobacco products. It hasContinue reading “FDA proposed updating its HPHC list in 2019; it needs to finish the job”

FDA proposed menthol ban in cigarettes is well done, except for the exceptions

On April 28, 2022, FDA released its proposed tobacco product standard prohibiting menthol cigarettes. The justification for prohibiting menthol as a characterizing flavor includes a comprehensive review of the effects of menthol on smoking, including why menthol promotes cigarette initiation and how it makes it harder to quit smoking. In addition to summarizing the behavioralContinue reading “FDA proposed menthol ban in cigarettes is well done, except for the exceptions”

APHA rapidly remedies error it made when accepting FSFW ad for AJPH

When I checked my email last Friday morning (April 15, 2022), I found a robust email conversation about the fact that the American Journal of Public Health, published by the American Public Health Association, featured an add from Philip Morris International’s Foundation for a Smokefree World soliciting grant proposals (examples above and below). The FSFWContinue reading “APHA rapidly remedies error it made when accepting FSFW ad for AJPH”